Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

(MedPage Today) -- The first-in-class RAS inhibitor daraxonrasib (Rasonque) in combination with chemotherapy showed promise as a first-line treatment for patients with metastatic pancreatic adenocarcinoma (PDAC), according to results from an early...

'Grand Slam' Pancreatic Cancer Drug Shows Promise as First-Line Treatment

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 20 November →